A Randomized, Double-blind, Placebo-controlled, Single Center and Single Dose Phase Ⅰ Study to Evaluate Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of AYP-101 S.C. Injection in Healthy Subjects
Latest Information Update: 08 Oct 2025
At a glance
- Drugs Polyenylphosphatidylcholine (Primary)
- Indications Subcutaneous fat disorders
- Focus Adverse reactions
- Sponsors AMI Pharm
Most Recent Events
- 08 Oct 2025 New trial record